Tert-butyl 4-[2-(4-bromo-2-fluorophenyl)-3-carbamoylpyrazolo[4,3-b]pyridin-7-yl]piperidine-1-carboxylate
C23H25BrFN5O3 — CID 164537633
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[2-(4-bromo-2-fluorophenyl)-3-carbamoylpyrazolo[4,3-b]pyridin-7-yl]piperidine-1-carboxylate
Tert-butyl 4-[2-(4-bromo-2-fluorophenyl)-3-carbamoylpyrazolo[4,3-b]pyridin-7-yl]piperidine-1-carboxylate (PubChem CID 164537633) has the molecular formula C23H25BrFN5O3 and a molecular weight of 518.39 g/mol. Its IUPAC name is tert-butyl 4-[2-(4-bromo-2-fluorophenyl)-3-carbamoylpyrazolo[4,3-b]pyridin-7-yl]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[2-(4-bromo-2-fluorophenyl)-3-carbamoylpyrazolo[4,3-b]pyridin-7-yl]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 164537633 |
| Molecular Formula | C23H25BrFN5O3 |
| Molecular Weight | 518.39 g/mol |
| Exact Mass | 517.11 |
| IUPAC Name | tert-butyl 4-[2-(4-bromo-2-fluorophenyl)-3-carbamoylpyrazolo[4,3-b]pyridin-7-yl]piperidine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCC(c2ccnc3c(C(N)=O)n(-c4ccc(Br)cc4F)nc23)CC1 |
| InChI | InChI=1S/C23H25BrFN5O3/c1-23(2,3)33-22(32)29-10-7-13(8-11-29)15-6-9-27-19-18(15)28-30(20(19)21(26)31)17-5-4-14(24)12-16(17)25/h4-6,9,12-13H,7-8,10-11H2,1-3H3,(H2,26,31) |
| InChIKey | YEYKRANFUBTNOK-UHFFFAOYSA-N |
| XLogP | 4.54 |
| TPSA | 103.34 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 518.39 |
| LogP ≤ 5 | 4.54 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164537633 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.